Annual report pursuant to Section 13 and 15(d)

Acquisitions (Tables)

v3.24.2.u1
Acquisitions (Tables)
12 Months Ended
Jun. 30, 2024
Lunaphore Technologies SA.  
Notes Tables  
Schedule of the aggregate purchase price of the acquisitions that was allocated to the assets acquired and liabilities assumed The fair values of the assets acquired and liabilities assumed as of the acquisition date and the updated final amounts as of June 30, 2024 are as follows (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

​

Preliminary allocation at acquisition date

​

Adjustments to fair value

​

Final allocation at June 30, 2024

Current assets

$

12,512

​

$

(357)

​

$

12,155

Equipment and other long-term assets

 

1,470

​

​

​

​

 

1,470

Intangible assets:

​

​

​

​

​

​

​

​

Developed technologies

 

60,300

​

​

​

​

 

60,300

Tradenames

 

4,900

​

​

​

​

 

4,900

Customer relationships

 

1,200

​

​

​

​

 

1,200

Goodwill

 

102,560

​

​

2,090

​

 

104,650

Total assets acquired

 

182,942

​

​

1,733

​

 

184,675

​

​

​

​

​

​

​

​

​

Liabilities

 

7,096

​

​

​

​

 

7,096

Deferred income taxes, net

 

5,768

​

​

2,104

​

 

7,872

Net assets acquired

$

170,078

​

$

(371)

​

$

169,707

​

​

​

​

​

​

​

​

​

Cash paid

 

166,426

​

​

3,281

​

 

169,707

Estimated Net Working Capital

​

3,652

​

​

(3,652)

​

​

—

Net assets acquired

$

170,078

​

$

(371)

​

$

169,707

Namocell Inc  
Notes Tables  
Schedule of the aggregate purchase price of the acquisitions that was allocated to the assets acquired and liabilities assumed Net sales and operating loss of this business included in Bio-Techne's consolidated results of operations for the twelve months ended June 30, 2023 were approximately $6.4 million and $9.3 million, respectively. The fair values of the assets acquired and liabilities assumed as of the acquisition date and the updated final amounts as of June 30, 2023 are as follows (in thousands):

​

​

​

​

​

​

    

​

​

​

Namocell Inc

Current assets, net of cash

​

$

3,248

Equipment and other long-term assets

​

 

405

Intangible assets:

​

 

  

Developed technology

​

 

73,900

Trade name

​

 

700

Customer relationships

​

 

900

Non-competition agreement

​

​

100

Goodwill

​

 

51,257

Total assets acquired

​

 

130,510

​

​

​

​

Liabilities

​

 

546

Deferred income taxes, net

​

 

18,180

Net assets acquired

​

$

111,784

​

​

​

​

Cash paid, net of cash acquired

​

 

101,184

Additional consideration

​

 

10,600

Net assets acquired

​

$

111,784